日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

MicroRNA-138 regulation promotes the efficacy of oncolytic herpes virus G47Δ for malignant brain tumor therapy

MicroRNA-138调控促进溶瘤疱疹病毒G47Δ治疗恶性脑肿瘤的疗效

Kanayama, Seisaku; Haraguchi, Takeshi; Iba, Hideo; Tanaka, Minoru; Todo, Tomoki

Author Correction: Intratumoral oncolytic herpes virus G47∆ for residual or recurrent glioblastoma: a phase 2 trial

作者更正:瘤内注射溶瘤性疱疹病毒 G47∆ 治疗残留或复发性胶质母细胞瘤:一项 II 期试验

Todo, Tomoki; Ito, Hirotaka; Ino, Yasushi; Ohtsu, Hiroshi; Ota, Yasunori; Shibahara, Junji; Tanaka, Minoru

Epithelial-Mesenchymal Transition and Genetically Driven Early Tumor Seedings in Extraneural Metastasis of Glioblastoma

胶质母细胞瘤神经外转移中的上皮-间质转化和基因驱动的早期肿瘤播散

Kanayama, Seisaku; Watanabe, Kentaro; Tanaka, Minoru; Takita, Junko; Todo, Tomoki

A brave new framework for glioma drug development

胶质瘤药物研发的新框架

Hotchkiss, Kelly M; Karschnia, Philipp; Schreck, Karisa C; Geurts, Marjolein; Cloughesy, Timothy F; Huse, Jason; Duke, Elizabeth S; Lathia, Justin; Ashley, David M; Nduom, Edjah K; Long, Georgina; Singh, Kirit; Chalmers, Anthony; Ahluwalia, Manmeet S; Heimberger, Amy; Bagley, Stephen; Todo, Tomoki; Verhaak, Roel; Kelly, Patrick D; Hervey-Jumper, Shawn; de Groot, John; Patel, Anoop; Fecci, Peter; Parney, Ian; Wykes, Victoria; Watts, Colin; Burns, Terry C; Sanai, Nader; Preusser, Matthias; Tonn, Joerg Christian; Drummond, Katharine J; Platten, Michael; Das, Sunit; Tanner, Kirk; Vogelbaum, Michael A; Weller, Michael; Whittle, James R; Berger, Mitchel S; Khasraw, Mustafa

Neoadjuvant use of oncolytic herpes virus G47Δ prevents local recurrence after insufficient resection in tongue cancer models

在舌癌模型中,新辅助使用溶瘤性疱疹病毒G47Δ可预防切除不彻底后的局部复发

Inoue, Kosuke; Ito, Hirotaka; Iwai, Miwako; Tanaka, Minoru; Mori, Yoshiyuki; Todo, Tomoki

EJS-3 How do we, as a society, respond to COVID-19?

EJS-3 我们作为一个社会,应该如何应对 COVID-19?

Todo, Tomoki; Ino, Yasushi; Ohtsu, Hiroshi; Shibahara, Junji; Tanaka, Minoru; Ohmagari, Norio

Efficacy of a third-generation oncolytic herpes simplex virus in refractory soft tissue sarcoma xenograft models

第三代溶瘤性单纯疱疹病毒在难治性软组织肉瘤异种移植模型中的疗效

Hatta, Masahiko; Kaibori, Masaki; Matsushima, Hideyuki; Yoshida, Terufumi; Okumura, Tadayoshi; Hayashi, Mikio; Yoshii, Kengo; Todo, Tomoki; Sekimoto, Mitsugu

Efficacy of cancer-specific anti-podoplanin CAR-T cells and oncolytic herpes virus G47Δ combination therapy against glioblastoma.

癌症特异性抗足蛋白 CAR-T 细胞和溶瘤疱疹病毒 G47Δ联合疗法治疗胶质母细胞瘤的疗效

Chalise Lushun, Kato Akira, Ohno Masasuke, Maeda Sachi, Yamamichi Akane, Kuramitsu Shunichiro, Shiina Satoshi, Takahashi Hiromi, Ozone Sachiko, Yamaguchi Junya, Kato Yukinari, Rockenbach Yumi, Natsume Atsushi, Todo Tomoki

Oncolytic Virus Therapy with HSV-1 for Hematological Malignancies

使用 HSV-1 溶瘤病毒疗法治疗血液系统恶性肿瘤

Ishino, Ryo; Kawase, Yumi; Kitawaki, Toshio; Sugimoto, Naoshi; Oku, Maki; Uchida, Shumpei; Imataki, Osamu; Matsuoka, Akihito; Taoka, Teruhisa; Kawakami, Kimihiro; van Kuppevelt, Toin H; Todo, Tomoki; Takaori-Kondo, Akifumi; Kadowaki, Norimitsu

Oncolytic herpes virus G47Δ works synergistically with CTLA-4 inhibition via dynamic intratumoral immune modulation

溶瘤疱疹病毒G47Δ通过动态的肿瘤内免疫调节与CTLA-4抑制剂产生协同作用。

Sugawara, Kotaro; Iwai, Miwako; Ito, Hirotaka; Tanaka, Minoru; Seto, Yasuyuki; Todo, Tomoki